Pàgina inicial > Resultats de la cerca: Fortuny, Joan
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.03 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
8 p, 390.2 KB Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children / Schmiedl, Sven (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Germany) ; Fischer, Rainald (Pneumologische Praxis München-Pasing, Munich, Germany) ; Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (Novartis Farmacéutica (Barcelona, Catalunya)) ; Klungel, Olaf H. (Utrecht University, the Netherlands) ; Reynolds, Robert (Epidemiology, Pfizer, New York, United States of America) ; Gerlach, Roman (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Tauscher, Martin (National Association of Statutory Health Insurance Physicians of Bavaria, Germany) ; Thürmann, Petra (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany) ; Hasford, Joerg (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany) ; Rottenkolber, Marietta (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany)
Respiratory drugs are widely used in children to treat labeled and non-labeled indications but only some data are available quantifying comprehensively off-label usage. Thus, we aim to analyse drug utilisation and off-label prescribing of respiratory drugs focusing on age- and indication-related off-label use. [...]
2014 - 10.1371/journal.pone.0105110
PloS one, Vol. 9 (september 2014)  
Registre complet - Creative Commons
2.
9 p, 3.3 MB Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007-2010 / Ferrer, Pili (Fundació Institut Català de Farmacologia) ; Sabaté, Mònica (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Ballarín, Elena (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (RTI Health Solutions) ; Rottenkolber, Marietta (Diabetes Research Group, Medical Department 4, University Hospital Munich, Campus Innenstadt, Ludwig-Maximilians-Universität, Ziemssenstr 1) ; Schmiedl, Sven (Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten-Herdecke University, Alfred Herrhausen-Strasse 50) ; Laporte Rosselló, Joan-Ramón (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fundació Institut Català de Farmacologia
The online version of this article (doi:10. 1186/s40064-015-1398-4) contains supplementary material, which is available to authorized users.
2015 - 10.1186/s40064-015-1398-4
SpringerPlus, Vol. 4 (october 2015)  
Registre complet - Creative Commons
3.
10 p, 619.3 KB Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial / Rottenkolber, Marietta (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Fischer, Rainald (Pneumologische Praxis Muenchen - Pasing, Munich, Germany) ; Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (Novartis Farmaceutica SA) ; Reynolds, Robert (Pfizer Research & Development, New York, USA) ; Amelio, Justyna (Amgen Ltd, Uxbridge, UK) ; Gerlach, Roman (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Tauscher, Martin (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Thürmann, Petra (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany) ; Hasford, Joerg (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Schmiedl, Sven (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany)
After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS). [...]
2015 - 10.1186/s12890-015-0051-x
BMC Pulmonary Medicine, Vol. 15 (may 2015)  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Fortuny, Jordi
54 Fortuny, Josep
6 Fortuny, Josep M
7 Fortuny, Josep M.
1 Fortuny, Josep M. (Josep Maria),
13 Fortuny, Josep M.,
30 Fortuny, Josep M..
2 Fortuny, Josep,
2 Fortuny, José Ma.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem